In addition to providing excellent care, Memorial Sloan Kettering is constantly working to improve treatment for lung cancer through clinical trials. Participating in a clinical trial may give you access to treatments that are not widely available, and may offer additional options if your cancer has returned after standard treatment. It’s also a way to make a contribution to the fight against cancer.
Our physicians lead a large number of clinical trials that test new drugs and drug combinations, surgical and radiation therapy techniques, innovative diagnostic technologies, and strategies for preserving quality of life during and after treatment.
We are also conducting a number of clinical trials to test the effectiveness of molecular profiling in treating non-small cell lung cancer. If the molecular makeup of your tumor matches certain eligibility criteria, your doctor may offer you the opportunity to participate in a clinical trial.
Our experts can help to determine which clinical trials are right for you. The following clinical trials for lung cancer are currently enrolling new patients. To learn more about a particular study, choose from the list below. For more information about any of our clinical trials, call our physician referral service at 866-MSK-LUNG (866-675-5864), or talk with your doctor.
Learn more about clinical trials.